Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

61.56
Delayed Data
As of Jul 02
 +0.61 / +1.00%
Today’s Change
47.36
Today|||52-Week Range
68.75
+7.04%
Year-to-Date

Today’s Trading

Previous close60.95
Today’s open60.95
Day’s range-- - --
Volume4,721,837
Average volume (3 months)5,072,826
Market cap$59.1B
Dividend yield2.19%
Data as of 07/02/2015

Growth & Valuation

Earnings growth (last year)+139.61%
Earnings growth (this year)+2.49%
Earnings growth (next 5 years)+1.70%
Revenue growth (last year)-0.47%
P/E ratio19.2
Price/Sales2.43
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc-0.02-0.10%
VBLTVascular Biogenics L...+0.05+0.81%
NEPTNeptune Technologies...-0.03-2.26%
Data as of 07/02/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)$1.29
Annual revenue (last year)$20.3B
Annual profit (last year)$3.1B
Net profit margin15.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers